Omnyx was created through collaboration with more than 30 thought leading pathologists from 13 academic medical centers and research laboratories across the globe, including hands-on input from UPMC pathologists. As a result of this collaboration, a highly intuitive and usable Omnyx Pathologist Workstation was developed and includes two core functions: the Pathologist Worklist and the Image Viewer.
Flexible list filtering and sorting for prioritization
Consolidated view of all accessioned cases — even those in the research lab being processed
Control of personal organization criteria to automatically filter cases into virtual piles
At-a-glance case previews with a quick summary, including a micro tray overview to organize cases
Enterprise-wide remote access enabling case organization from any workstation utilizing the central Omnyx Workflow Server
Case sharing that facilitates collaboration and teaching
High quality image display with fast image viewing over standard hospital and other networks
Digital organization of cases prevents loss and separation of slides and paperwork
Case accessibility by multiple people from multiple locations
Timeline display of individual’s prior case history
AP-LIS data integrated into case detail, including gross description and prior case information
Auto-tracking of case status, notifying research pathologists of cases awaiting scans, ready for review, and review complete
Multitasking support enables pathologists to seamlessly toggle between cases and maintain context at all times
Remote access over hospital and other VPN connections
Intuitive tools for digital image review such as magnification and rotation plus annotations and precision measurements
Instant return to marked areas of interest
Familiar slide tray view illustrates case complexity, stain types, tissue orientation and whether slide has been previously viewed
Simultaneous view of up to six slides with synchronized navigation
Area-of-interest snapshots can be shared with other pathologists or used in conferences
Omnyx is CE Marked under the European Union’s ‘In Vitro Diagnostics Directive’ for routine clinical use in the EU for VL4 and DPS and not any other products.
Omnyx is cleared by Health Canada for routine diagnostic use for VL4 and DPS and not any other products.
In the US, Omnyx products are for research only and not for use in diagnostic procedures.
US Patents 8,463,741 and 8,396,269